Skip to content

The Impact of a Helplessness and Recovery of an Empowerment Intervention on People Diagnosed With Schizophrenia: Findings From a Randomized Controlled Trial

The Effectiveness of Hopelessness and Helplessness on Recovery Rate Among People Diagnosed With Schizophrenia

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02968667
Enrollment
102
Registered
2016-11-18
Start date
2015-11-30
Completion date
2016-05-31
Last updated
2016-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychotic Disorders

Brief summary

A randomized controlled trial was conducted from November 2015 and May 2016 with 112 participants of people diagnosed with schizophrenia. Participants aged 18 years or older with Diagnostic Statistical Manual (DSM-V) schizophrenia or schizoaffective disorder from outpatient mental health clinics in Jordan, were randomly assigned participants either to receive 6 weeks of a booklet form of intervention with face to face discussion, and treatment as usual (TAU) (intervention, n = 56), or TAU (control, n = 56). Participants were assessed at baseline, immediately post-intervention (post-treatment1) and at three months follow-up. The primary outcome measure was change in helplessness score . Secondary outcomes for PDwS were psychiatric symptoms, recovery rate and quality of life.

Detailed description

A randomized controlled trial was conducted from November 2015 and May 2016 with 112 participants of people diagnosed with schizophrenia. Participants aged 18 years or older with DSM-V schizophrenia or schizoaffective disorder from outpatient mental health clinics in Jordan, were randomly assigned participants either to receive 6 weeks of a booklet form of intervention with face to face discussion, and treatment as usual \[TAU\] (intervention, n = 56), or TAU (control, n = 56). Participants were assessed at baseline, immediately post-intervention (post-treatment1) and at three months follow-up. The primary outcome measure was change in helplessness score . Secondary outcomes for PDwS were psychiatric symptoms, recovery rate and quality of life.

Interventions

BEHAVIORALEmpowerment

6 weeks of empowerment program and supported face to face discussion

Sponsors

Fakeeh College for Medical Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
16 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Adult aged 16 years or more * Able to read and write in an Arabic * Able to consent * Diagnosed with schizophrenia * Volunteers

Exclusion criteria

* Learning disability * Not able to read or write

Design outcomes

Primary

MeasureTime frameDescription
Modified Learned HelplessnessUp to 6 monthsOutcome was measured at baseline (November) and immediately post intervention (February) and at three months follow up (May)

Secondary

MeasureTime frameDescription
Empowerment levelUp to 6 monthsOutcome was measured at baseline (November) and immediately post intervention (February) and at three months follow up (May)
Psychiatric symptomsUp to 6 monthsOutcome was measured at baseline (November) and immediately post intervention (February) and at three months follow up (May)
recovery assessment scaleUp to 6 monthsOutcome was measured at baseline (November) and immediately post intervention (February) and at three months follow up (May)
Quality of lifeUp to 6 monthsOutcome was measured at baseline (November) and immediately post intervention (February) and at three months follow up (May)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026